PharmaNet Agrees To $28.5M Securities Settlement
Drug development services company PharmaNet Development Group Inc.—formerly known as SFBC International Inc.—has agreed to settle consolidated shareholder derivative litigation that related allegations of rampant nepotism, unethical clinical testing practices and...To view the full article, register now.
Already a subscriber? Click here to view full article